PBH Prestige Consumer Healthcare Inc

  1. Stocks
  2. Healthcare
  3. NYSE: PBH

Price (delayed)

$71.22

Market cap

$3.54B

P/E Ratio

N/A

Dividend/share

N/A

EPS

-$1.6

Enterprise value

$4.69B

Prestige Consumer Healthcare markets, sells, manufactures and distributes consumer healthcare products to retail outlets throughout the U.S. and Canada, Australia, and in certain other international markets. The Company's diverse portfolio ...

Highlights
The quick ratio has increased by 23% YoY and by 11% from the previous quarter
The company's debt fell by 16% YoY and by 5% QoQ
The equity has contracted by 5% YoY but it has grown by 4.2% from the previous quarter
The EPS has plunged by 138% YoY
The net income has plunged by 138% YoY
Sector: Healthcare
Industry: Medical Distribution
Website: http://www.prestigebrands.com
Peers: PFE PG NVS JNJ

Key stats

What are the main financial stats of PBH
Market
Shares outstanding
49.65M
Market cap
$3.54B
Enterprise value
$4.69B
Valuations
Price to earnings (P/E)
N/A
Price to book (P/B)
2.21
Price to sales (P/S)
3.12
EV/EBIT
N/A
EV/EBITDA
277.93
EV/Sales
4.13
Earnings
Revenue
$1.13B
EBIT
-$19.94M
EBITDA
$16.86M
Free cash flow
$232.04M
Per share
EPS
-$1.6
Free cash flow per share
$4.67
Book value per share
$32.26
Revenue per share
$22.8
TBVPS
$9.72
Balance sheet
Total assets
$3.34B
Total liabilities
$1.74B
Debt
$1.21B
Equity
$1.6B
Working capital
$266.35M
Liquidity
Debt to equity
0.76
Current ratio
3.09
Quick ratio
1.87
Net debt/EBITDA
68.2
Margins
EBITDA margin
1.5%
Gross margin
55.2%
Net margin
-7.1%
Operating margin
-1.8%
Efficiency
Return on assets
-2.4%
Return on equity
-5.3%
Return on invested capital
-1.3%
Return on capital employed
-0.6%
Return on sales
-1.8%
Dividend
Dividend yield
N/A
DPS
N/A
Payout ratio
N/A

PBH stock price

How has the Prestige Consumer Healthcare stock price performed over time
Intraday
2.03%
1 week
4.64%
1 month
-2.77%
1 year
14.5%
YTD
16.33%
QTD
-1.85%

Financial performance

How have Prestige Consumer Healthcare's revenue and profit performed over time
Revenue
$1.13B
Gross profit
$626.4M
Operating income
-$20.72M
Net income
-$80.67M
Gross margin
55.2%
Net margin
-7.1%
The net income has plunged by 138% YoY
The company's net margin has shrunk by 137% YoY but it rose by 2.7% QoQ
PBH's operating margin has dropped by 106% year-on-year
The company's operating income has shrunk by 106% YoY

Growth

What is Prestige Consumer Healthcare's growth rate over time

Valuation

What is Prestige Consumer Healthcare stock price valuation
PBH P/E details
P/E
N/A
P/B
2.21
P/S
3.12
EV/EBIT
N/A
EV/EBITDA
277.93
EV/Sales
4.13
The EPS has plunged by 138% YoY
PBH's price to book (P/B) is 30% higher than its 5-year quarterly average of 1.7 and 11% higher than its last 4 quarters average of 2.0
The equity has contracted by 5% YoY but it has grown by 4.2% from the previous quarter
The price to sales (P/S) is 30% higher than the 5-year quarterly average of 2.4 and 20% higher than the last 4 quarters average of 2.6
Prestige Consumer Healthcare's revenue has increased by 2.3% YoY

Efficiency

How efficient is Prestige Consumer Healthcare business performance
Prestige Consumer Healthcare's return on assets has shrunk by 142% YoY
PBH's ROE has shrunk by 141% YoY
Prestige Consumer Healthcare's ROIC has plunged by 107% YoY and by 8% from the previous quarter
The ROS has plunged by 106% YoY

Dividends

What is PBH's dividend
DPS
N/A
Dividend yield
N/A
Payout ratio
N/A

There are no recent dividends present for PBH.

Financial health

How did Prestige Consumer Healthcare financials performed over time
Prestige Consumer Healthcare's total assets is 92% higher than its total liabilities
The quick ratio has increased by 23% YoY and by 11% from the previous quarter
The current ratio is up by 21% year-on-year and by 3.3% since the previous quarter
The company's debt is 24% lower than its equity
The company's debt fell by 16% YoY and by 5% QoQ
Prestige Consumer Healthcare's debt to equity has decreased by 12% YoY and by 8% from the previous quarter

All financial data is based on trailing twelve months (TTM) periods - updated quarterly, unless otherwise specified.